EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 4

Lavender Lavandula angustifolia Mill.

Also called: English lavender, common lavender, lavender oil, Lavandula officinalis

An aromatic evergreen shrub native to the Mediterranean region. Its flowering tops yield an essential oil used in oral capsules, aromatherapy and skin products; lavender is also sold as tea and syrup.

Category
Botanical
Part used
Flowering tops; essential oil
Strongest evidence
B Some positive trials
Reviewed
2026-10-28

Class 1 Well studied in people. A 2019 meta-analysis (Phytomedicine) included 65 RCTs (7,993 participants) of lavender for anxiety, given by inhalation, massage or orally (Silexan capsules), and pooled 37 of them (3,964 participants). [4]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Lavender does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Lavender, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Anxiety, including anxiety with depressive symptoms (oral lavender oil product)BStudies suggest an oral lavender oil product might be beneficial; limitations include small samples, lack of independent funding and testing, and low participant diversity. [1]
Depressive symptomsCEarly reports of small studies suggest oral lavender capsules or tea might reduce depressive symptoms; NCCIH urges caution. Topical lavender does not appear to affect depression symptoms. [1]
Menopause-related sexual dysfunctionCOne preliminary study of 72 postmenopausal women aged 50–65 found an oral lavender oil product might offer some relief; more reliable evidence is needed. [1]
Aromatherapy for anxiety, stress, depression, pain, sleep quality and insomniaCNCCIH states it is unclear whether lavender oil aromatherapy helps these outcomes. [1]

Main constituents: Linalool and linalyl acetate (major constituents); 1,8-cineole [2]

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated April 15, 2019.

    Details and sources
  • Pregnancy and breastfeeding
    EU monograph: safety during pregnancy and lactation has not been established …

    2 statements in the profile.

    Details and sources
  • Interactions with medicines
    2 listed

    Sedative drugs and herbs; CNS depressants and anticonvulsants

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    1 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    EU HMPC monograph on lavender oil (traditional use; adopted 27 March 2012), adolescents, adults and elderly: oral daily dose 20-80 mg …

    Details and sources
  • Likely safe in food amounts. Oral products may be safe short-term at amounts tested in studies but may cause diarrhea, headache, nausea or burping. [1]
  • Aromatherapy is considered possibly safe but may cause headache or coughing. [1]
  • Topical use may cause allergic skin reactions; photosensitivity has also been reported. [2]
  • A few cases of breast tissue swelling were reported in children using lavender-containing topical products; it is unclear whether lavender caused this. [1]
  • Avoid long-term oral or topical use with hormone-sensitive cancers. Pregnant and nursing women should avoid excessive internal use. [2]
  • Little is known about whether lavender is safe during pregnancy or while breastfeeding. [1]
Interactions

Interactions

Lavender
From the table below 2 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of Lavender
WithWhat happens
Sedative drugs and herbsLavender might theoretically interact with sedatives, which matters especially before surgery. [1]
CNS depressants and anticonvulsantsLavender may increase narcotic and sedative effects. [2]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Regulation

Regulatory status

  • US: oral lavender oil products, capsules, tea and syrup are marketed as dietary supplements, which are not approved by FDA before they are sold. [1]
  • EU: lavender oil has a European Union herbal monograph based on traditional use for relief of mild symptoms of mental stress and exhaustion and to aid sleep, in adults and children over 12. [3]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Volatile oil consisting chiefly of linalool and linalyl acetate (also caryophyllene epoxide) Monoterpenes (volatile oil) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 1 entry naming lavender oil (as one component of a multi-ingredient product) (NDI 908 submitted 2016-01-19). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of lavender or lavender oil was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
  • NTP technical reports list checked 2026-10-29: no report on lavender. [P4]

Liver (NIH LiverTox)

  • LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated April 15, 2019. [P1]

Interactions with medicines

  • Sedative drugs and herbs: Lavender might theoretically interact with sedatives, which matters especially before surgery. [P5]
  • CNS depressants and anticonvulsants: Lavender may increase narcotic and sedative effects. [P6]
  • Other medicinal products: EU monograph for oral lavender oil: interactions none reported. [P7]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • Lavender essential oil is particularly susceptible to adulteration, often with lavandin (Lavandula x intermedia) essential oil; mass spectrometry and chemometric techniques are used to detect it (Rashed et al., 2025 review). [P8]
  • GC-MS profiling of four commercial lavender oils found some samples with unusually high non-characteristic fatty acid esters and synthetic glycols, suggesting dilution or adulteration with carrier oils or formulation additives (Abouelela et al., 2026). [P9]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P10]
  • Compliance with the Ph. Eur. lavender oil monograph (ref. 07/2010:1338) — The EU herbal monograph specifies that the lavender oil complies with the Ph. Eur. monograph and is obtained by steam distillation from the flowering tops of Lavandula angustifolia. [P7]
  • GC-MS profile (linalool, linalyl acetate; lavandin and carrier-oil markers) — Adulteration with lavandin oil and dilution with carrier oils or synthetic glycols have been reported. [P9]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P11]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • EU HMPC monograph on lavender oil (traditional use; adopted 27 March 2012), adolescents, adults and elderly: oral daily dose 20-80 mg; as bath additive 1 to 3 g per full bath once daily; use in children under 12 not recommended. [P7]

Pregnancy and breastfeeding

  • EU monograph: safety during pregnancy and lactation has not been established; in the absence of sufficient data, use during pregnancy and lactation is not recommended. [P7]
  • NCCIH: little is known about whether lavender is safe during pregnancy or while breastfeeding. [P5]

Sources for this profile

  1. NIH LiverTox. Lavender (last update April 15, 2019), 2019-04-15. ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  4. National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  5. NCCIH. Lavender: Usefulness and Safety (last updated February 2025), 2025-02. nccih.nih.gov
  6. Memorial Sloan Kettering Cancer Center. About Herbs: Lavender (last updated June 4, 2021), 2021-06-04. mskcc.org
  7. European Medicines Agency, HMPC. Community herbal monograph on Lavandula angustifolia Miller, aetheroleum (EMA/HMPC/143181/2010, adopted 27 March 2012), 2012-03-27. ema.europa.eu
  8. Rashed MMA, et al. Traceability, authentication, and quality control of food-grade lavender essential oil: a comprehensive review. Adv Colloid Interface Sci 2025;340:103466 (PMID 40049066), 2025-06. pubmed.ncbi.nlm.nih.gov
  9. Abouelela MB, et al. Uncovering adulteration and quality variations in commercial lavender essential oils from the Egyptian market using GC-MS and chemometrics. Sci Rep 2026;16(1):12735 (PMID 42000791), 2026-04-18. pubmed.ncbi.nlm.nih.gov
  10. eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  11. GBIF species API: IUCN Red List category for Lavandula angustifolia Mill., 2026-10-29. api.gbif.org
Sources

Sources

  1. NCCIH. Lavender: Usefulness and Safety (last updated February 2025), 2025-02. nccih.nih.gov
  2. Memorial Sloan Kettering Cancer Center. About Herbs: Lavender (last updated June 4, 2021), 2021-06-04. mskcc.org
  3. European Medicines Agency. Lavandulae aetheroleum: herbal medicinal product (monograph 13/06/2012; public summary 16/06/2014), 2014-06-16. ema.europa.eu
  4. Donelli D, et al. Effects of lavender on anxiety: A systematic review and meta-analysis. Phytomedicine 2019;65:153099 (PMID 31655395), 2019-09-26. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.